Riboflavin-ultraviolet light induced cross-linking in endothelial decompensation

Acta Ophthalmol. 2008 Aug;86(5):549-51. doi: 10.1111/j.1600-0420.2007.01085.x. Epub 2008 Jun 4.

Abstract

Purpose: To evaluate the potential of collagen cross-linking in the treatment of corneal oedema caused by endothelial decompensation.

Methods: Riboflavin-ultraviolet (UV) treatment induces cross-linking and reduces stromal swelling. Eleven patients with corneal oedema were treated. The technique comprised: epithelial abrasion; instillation of 0.1% riboflavin in saline, and 5.4 J/cm(2) illumination with 365 nm UV-A light over approximately 30 mins (3 mW/cm(2)).

Results: A reduction in corneal thickness was observed in 10 patients. The majority also experienced improvement in vision. The effect occurred over weeks and lasted for months.

Conclusions: The study shows a potential application of collagen cross-linking in the management of patients with corneal oedema. Experimental and additional clinical studies are necessary in order to define the precise indications for this type of treatment.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Collagen / metabolism*
  • Corneal Edema / drug therapy*
  • Corneal Edema / etiology
  • Corneal Edema / metabolism
  • Corneal Stroma / metabolism
  • Endothelium, Corneal / pathology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Photochemotherapy
  • Photosensitizing Agents / therapeutic use*
  • Riboflavin / therapeutic use*
  • Treatment Outcome
  • Ultraviolet Rays*
  • Visual Acuity / physiology

Substances

  • Photosensitizing Agents
  • Collagen
  • Riboflavin